Immix Biopharma IMMX
NASDAQ IMMX
$9.76 -0.47 (-4.59%)
As of: Oct 2, 2026 · 2:18 PM EDT

Immix Biopharma (IMMX) Return on Assets [ROA] (2022 - 2026)

Updated

Immix Biopharma's Return on Assets [ROA] was -23.84% in Q2 2026, up 106.35 percentage points from -130.19% a year earlier and up 11.03 percentage points from the prior quarter.

Analysis

Immix Biopharma (IMMX) Return on Assets [ROA] (2022 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Immix Biopharma came in at -46.07%, up 55.15 percentage points from FY2024.

  • Return on Assets [ROA] shows a four-year change of +214.27 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Assets [ROA] was -101.22% in FY2024 (-11.68 pp), -89.54% in FY2023 (-39.82 pp), -49.73% in FY2022 (+210.62 pp) and -260.35% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] in data going back to Q1 2022.
  • Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of +4.93 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 106.35 percentage points); the worst was Q2 2025 (a drop of 69.30 percentage points).
  • Per Business Quant data, IMMX's Return on Assets [ROA] in the three quarters before Q2 2026 was -34.87% (Q1 2026), -47.13% (Q4 2025) and -131.95% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Immix Biopharma 743.97 Mn 743.97 Mn - -23.84%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.84%
Mar 31, 2026 -34.87%
Dec 31, 2025 -47.13%
Sep 30, 2025 -131.95%
Jun 30, 2025 -130.19%
Mar 31, 2025 -97.62%
Dec 31, 2024 -90.24%
Sep 30, 2024 -81.67%
Jun 30, 2024 -60.89%
Mar 31, 2024 -67.91%
Dec 31, 2023 -73.56%
Sep 30, 2023 -74.87%
Jun 30, 2023 -79.44%
Mar 31, 2023 -66.83%
Dec 31, 2022 -50.95%
Sep 30, 2022 -149.03%
Jun 30, 2022 -133.25%
Mar 31, 2022 -129.28%
API Access

Immix Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMMX&period=max&api_key=YOUR_API_KEY